2022-2023 EVENTS

2022 Events

28 Aug - 01 Sep 2022
The International Surgical Week (ISW)
Kuala Lumpur

31 Aug – 2 Sept 2022
Medical Fair Asia
Marina Bay Sands, Singapore

3-9 September
Medical Fair Asia
Digital, Online

9-10 September 2022
World Pediatrics Conference
Bangkok, Thailand

9-10 September 2022
World Heart and Cardiothoracic Surgery Conference
Bangkok, Thailand

19-21 September 2022
23rd SE-Asian Healthcare & Pharma Show
Kuala Lumpur

27-29 September 2022
Smart Healthcare Expo (Health Malaysia)

27-29 September 2022
Asia Pandemic Congress
Kuala Lumpur Convention Centre

19-20 September 2022
23nd Global Nursing Education Conference
Brisbane, Australia

30 Sep - 2 Oct 2022
Malaysia International Dental Show (MIDS)
Sunway Pyramid Convention Centre, Subang Jaya, Malaysia

7-9 November 2022
Saudi International MedLab Expo
Riyadh International Convention and Exhibition Center

7-9 November 2022
Saudi International Pharma Expo
Riyadh International Convention and Exhibition Center

11-13 November 2022
Eldercare Exhibition and Conference Asia (ELDEX Asia 2022)
Suntex Singapore Exhibition and Convention Centre

14-15 November 2022
Healthcare Asia Pacific
Osaka, Japan

2023 Events

30 May – 1 June 2023
KL Convention Centre, Kuala Lumpur

13-15 September 2023
Medical Fair Thailand
BITEC, Bangkok

Free counters!

The National Pharmaceutical Regulatory Agency (NPRA) has reported 12 cases of adverse effects following the use of a recently recalled opioid medicine named Pholcodine.

Health director-general Dr Noor Hisham Abdullah said 17 instances of adverse effects were detected in the 12 cases reported.

“However, no reports involving anaphylaxis were received,” he said in a statement.

Yesterday, the Drug Control Authority under the health ministry directed the recall of Pholcodine, which is used for the treatment of non-productive (dry) cough.

It is also used in combination with other active substances for the treatment of symptoms of cold and flu.

Alpro Pharmacy chief pharmacist and engagement director Lim En Ni said the medicine was recalled due to possible drug interaction with a neuromuscular blocking agent, which is commonly used as part of the regime in general anaesthesia during medical surgery.

It can cause anaphylaxis if the patient had taken pholcodine-containing products in the past 12 months.

“Anaphylaxis is a serious, life-threatening allergic reaction,” she said in a statement on Tuesday.

Lim said consumers who had purchased the medicine and had not consumed it could return it to the pharmacy or healthcare facility that had supplied it.

She advised consumers who had used pholcodine products in the past 12 months to visit the nearest pharmacy to have a medication list prepared for them so that they could show it to their surgeon or doctor if they had to undergo surgery for some problem or other.